NCT06286241尚未招募不适用
Comparison of the Complications in Multiple Myeloma Patients Who Received Autologous Stem Cell Transplantation Between in HEPA-filtered Room and Non-HEPA-filtered Room
适应症
试验速览
- 阶段
- 不适用
- 状态
- 尚未招募
- 入组人数
- 344
- 主要终点
- febrile neutropenia
研究概览
简要总结
The goal of this observational study is to comparison of the complications in multiple myeloma patients who received autologous stem cell transplantation between in HEPA-filtered room and non-HEPA-filtered room. The main questions it aims to answer are:
- The incidence of febrile neutropenia, infection, and duration of hospital stay
- 2-year progression free survival Participants will be collected the data of baseline diagnosis, treatment, treatment results and complications during admission and follow-up visits from hospital medical record.
研究设计
- 研究类型
- Observational
- 观察模型
- Cohort
- 时间视角
- Other
入排标准
- 年龄范围
- 18 Years 至 65 Years（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •aged 18 - 65 years old
- •Patients with multiple myeloma undergoing treatment with autologous stem cell transplantation and having a Hematopoietic Cell Transplantation-Specific Comorbidity Index (HCT-CI) score less than or equal to 2
- •Patients must provide signed consent to participate in the research if they undergo ASCT after the study has been approved.
- •If patients undergo ASCT before the study approval, retrospective data will be collected.
排除标准
- •Patients with concomitant other types of cancer
- •Patients who refuse to participate in the study.
结局指标
主要结局
febrile neutropenia
时间窗: during admission
incidence of febrile neutropenia
Infection
时间窗: during admission
incidence of Infection
duration of admission
时间窗: during admission
duration of admission
progression free survival
时间窗: 2 years
duration of survival
次要结局
未报告次要终点
研究者
Chutima Kunacheewa
lecturer
Siriraj Hospital
相似试验
尚未招募
不适用
Survival Outcomes of Multiple Myeloma Patients Admitted on Assiut Clinical Hematology UnitMultiple Myeloma Survival OutcomeNCT05119205Assiut University64
尚未招募
早期 1 期
An Clinical Study of NKG2D-CAR-NK Cells for the Treatment of Refractory Recurrent Multiple MyelomaMultiple MyelomaNCT06379451Changzhou No.2 People's Hospital9
进行中（未招募）
不适用
Comparative Trial inMultiple Myeloma Patients of Oral Ibandronic Acid versus Intravenous Zoledronate: a phase III studyMultiple MyelomaEUCTR2005-003770-23-ATF. Hoffmann-La Roche Ltd424
进行中（未招募）
不适用
Multiple Myeloma Outcomes Based on Maintenance Therapy Post Autologous Stem Cell TransplantMultiple MyelomaNCT05271630H. Lee Moffitt Cancer Center and Research Institute69
已完成
不适用
The Burden of Multiple Myeloma on Patients and Caregivers Quality of Life: a Canadian Real-World StudyCaregiver Subjective BurdenQuality of Life (QOL)Multiple MyelomaNCT06610045PeriPharm400